Daniel S Rosenbloom

10PUBLICATIONS
55CO-AUTHORS
Gene and molecular therapyInfant and child healthCell development, proliferation and deathRespiratory diseasesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 22, 2023
Potent targeted activator of cell kill molecules eliminate cells expressing HIV-1.

Carl J Balibar, Daniel J Klein, Beata Zamlynny

|Feb 15, 2023
Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study.

Regino P Gonzalez-Peralta, Stefan Wirth, Robert H Squires

|Oct 24, 2022
Prediction of frozen virus stability based on degradation mechanisms, real-time data and modeling.

Ying Homan, Daniel Rosenbloom, Sally Wong

|Apr 13, 2019
Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size.

Daniel I S Rosenbloom, Peter Bacchetti, Mars Stone

|Sep 29, 2018
Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.

Jin-Ku Lee, Zhaoqi Liu, Jason K Sa

|Feb 16, 2018
Life cycle synchronization is a viral drug resistance mechanism.

Iulia A Neagu, Jason Olejarz, Mark Freeman

Pageof 2